Successfully Defending Patents In Inter Partes Reexamination And Inter Partes Review Proceedings Before the USPTO By Matthew A. Smith


USPTO inter partes proceedings are not healthy for patents. Inter partes reexamination has resulted in the cancellation of all claims of a patent nearly 45% of the time. The probability of any single claim being canceled is likely above 70%. The primary appellant from the Examiner's decision in inter partes reexamination has been the Patent Owner nearly three times as often as it has been the Challenger.

The success rate of Challengers in inter partes proceedings could be caused by a number of things, including the lower burden of proof before the PTO, the broader claim construction, and tendency of the higher-placed PTO officials to pay little deference to the decision of junior examiners. Whatever the true causes, however, it is noticeably easier to defend patent rights before a jury than it is to recover them from inter partes PTO proceedings, which is why accused infringers often make use of these proceedings.

Please see full article below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Foley & Lardner LLP | Attorney Advertising

Written by:


Foley & Lardner LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.